Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study (vol 230, pg e971, 2024)

被引：0
|
作者：
Leroux-Roels, I
Maes, C.
Mancini, F.
机构：
来源：
JOURNAL OF INFECTIOUS DISEASES | 2024年 / 230卷 / 06期
关键词：
D O I：
10.1093/infdis/jiae564
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E1413 / E1413
页数：1
相关论文
共 15 条
  • [1] Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study
    Leroux-Roels, Isabel
    Maes, Cathy
    Mancini, Francesca
    Jacobs, Bart
    Sarakinou, Eleanna
    Alhatemi, Azhar
    Joye, Jasper
    Grappi, Silvia
    Cilio, Giulia Luna
    Serry-Bangura, Alimamy
    Vitali, Claudia G.
    Ferruzzi, Pietro
    Marchetti, Elisa
    Necchi, Francesca
    Rappuoli, Rino
    De Ryck, Iris
    Auerbach, Jochen
    Colucci, Anna M.
    Rossi, Omar
    Conti, Valentino
    Scorza, Francesco Berlanda
    Arora, Ashwani Kumar
    Micoli, Francesca
    Podda, Audino
    Nakakana, Usman N.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (04): : e971 - e984
  • [2] A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
    Obiero, Christina W.
    Ndiaye, Augustin G. W.
    Scire, Antonella Silvia
    Kaunyangi, Bonface M.
    Marchetti, Elisa
    Gone, Ann M.
    Schuette, Lena Dorothee
    Riccucci, Daniele
    Auerbach, Joachim
    Saul, Allan
    Martin, Laura B.
    Bejon, Philip
    Njuguna, Patricia
    Podda, Audino
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [3] Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
    Hatz, Christoph F. R.
    Bally, Bettina
    Rohrer, Susanne
    Steffen, Robert
    Kramme, Stefanie
    Siegrist, Claire-Anne
    Wacker, Michael
    Alaimo, Cristina
    Fonck, Veronica Gambillara
    VACCINE, 2015, 33 (36) : 4594 - 4601
  • [4] Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
    Riddle, Mark S.
    Kaminski, Robert W.
    Di Paolo, Claudio
    Porter, Chad K.
    Gutierrez, Ramiro L.
    Clarkson, Kristen A.
    Weerts, Hailey E.
    Duplessis, Christopher
    Castellano, Amy
    Alaimo, Cristina
    Paolino, Kristopher
    Gormley, Robert
    Fonck, Veronica Gambillara
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (12) : 908 - 917
  • [5] A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age
    Essink, Brandon
    Peterson, James
    Yacisin, Kari
    Lal, Himal
    Mirza, Sarah
    Xu, Xia
    Scully, Ingrid L.
    Scott, Daniel A.
    Gruber, William C.
    Jansen, Kathrin U.
    Watson, Wendy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2691 - 2699
  • [6] Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy US Adults: A Phase 1/2 Randomized Study
    Lin, Leyi
    Lyke, Kirsten E.
    Koren, Michael
    Jarman, Richard G.
    Eckels, Kenneth H.
    Lepine, Edith
    McArthur, Monica A.
    Currier, Jeffrey R.
    Friberg, Heather
    Moris, Philippe
    Keiser, Paul B.
    De la Barrera, Rafael
    Vaughn, David W.
    Paris, Robert M.
    Thomas, Stephen J.
    Schmidt, Alexander C.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (01): : 132 - 141
  • [7] Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study
    Erdem, Rahsan
    De Coster, Ilse
    Withanage, Kanchanamala
    Mercer, Laina D.
    Marchant, Arnaud
    Taton, Martin
    Cools, Nathalie
    Lion, Eva
    Cassels, Fred
    Higgins, Deborah
    Ivinson, Karen
    Locke, Emily
    Mahmood, Kutub
    Wright, Peter F.
    Gast, Chris
    White, Jessica A.
    Ackerman, Margaret E.
    Konopka-Anstadt, Jennifer L.
    Mainou, Bernardo A.
    Van Damme, Pierre
    VACCINE, 2023, 41 (10) : 1657 - 1667
  • [8] Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies (vol 13, pg 57, 2024)
    Wynne, Chris
    Balgos, Abundio
    Li, Jingxin
    Hamilton, Paul
    Tirador, Louie
    Jaen, Anjuli May
    Mo, Chen
    Yue, Zijing
    Ma, Ying
    Wang, Qingshuang
    Wen, Rendu
    Yao, Zheng
    Yu, Jiaping
    Yao, Wenrong
    Zhang, Jianhui
    Zheng, Hui
    Hong, Kunxue
    Zhu, Fengcai
    Liu, Yong
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (07) : 1723 - 1724
  • [9] Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial (vol 78, pg 1748, 2024)
    Pineda-Pena, Andrea-Clemencia
    Jiang, Qian
    Petit, Celine
    Korejwo-Peyramond, Joanna
    Donazzolo, Yves
    Latreille, Mathilde
    Homery, Marie-Claude
    Babin, Valerie
    Benamor, Sonia
    Pichon, Sylvie
    Guinet-Morlot, Francoise
    Minutello, Ada-Maria
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 1124 - 1124
  • [10] Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naive adults
    Kester, Kent E.
    Heppner, D. Gray, Jr.
    Moris, Philippe
    Ofori-Anyinam, Opokua
    Krzych, Urszula
    Tornieporth, Nadia
    McKinney, Denise
    Delchambre, Martine
    Ockenhouse, Christian F.
    Voss, Gerald
    Holland, Carolyn
    Beckey, Jolie Palensky
    Ballou, W. Ripley
    Cohen, Joe
    VACCINE, 2014, 32 (49) : 6683 - 6691
12